Your browser doesn't support javascript.
loading
Active screening for lung cancer increases smoking abstinence in Australia.
Marshall, Henry M; Vemula, Mounavi; Hay, Karen; McCaul, Elizabeth; Passmore, Linda; Yang, Ian A; Bowman, Rayleen V; Fong, Kwun M.
Afiliação
  • Marshall HM; University of Queensland Thoracic Research Centre, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Vemula M; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia.
  • Hay K; University of Queensland Thoracic Research Centre, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • McCaul E; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Passmore L; University of Queensland Thoracic Research Centre, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Yang IA; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia.
  • Bowman RV; University of Queensland Thoracic Research Centre, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Fong KM; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia.
Asia Pac J Clin Oncol ; 19(3): 374-384, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36437500
ABSTRACT

BACKGROUND:

Smoking cessation is an important screening component, but the evidence base to inform implementation is lacking. We report longitudinal smoking behavior in an Australian screening cohort and examine predictor variables associated with continued smoking.

METHODS:

Healthy current or former smokers (quit less than 15 years and ≥30-pack year smoking history) aged 60-74 years underwent CT screening at baseline, year 1 and year 2. Participants received brief smoking cessation advice and generic Quitline materials. Smoking status was self-reported every 6 months for 5 years. Mediators of smoking behavior, adjusted for sociodemographic, health and scan variables were explored using logistic regression modeling.

RESULTS:

Two hundred thirty-five participants were analyzed. One hundred eight (46%) were current smokers at enrolment. At baseline, current smokers' mean Fagerström Test for Nicotine Dependence was 4.9, and they had higher levels of lung cancer-specific distress and passive smoke exposure than former smokers. At 36 months, 33% of baseline smokers achieved sustained (≥6 months) smoking abstinence. Five (4%) former smokers relapsed at any point during the study. Continued smoking was positively associated with greater nicotine dependence and smoking pack-years, and negatively associated with cardiovascular disease, stroke, and lung cancer family history.

CONCLUSIONS:

This study provides the first data on smoking cessation rates in Australian lung cancer screenees and supports screening as a teachable moment. We identify several factors that identify smokers who may require more intensive smoking cessation interventions and could be used to develop effective smoking cessation as part of lung cancer screening, tailored to individual risk profiles.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tabagismo / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tabagismo / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article